Beating Adolescent Self-Harm (BASH): A randomised controlled trial comparing usual care versus usual care plus a smartphone self-harm prevention app (BlueIce) in young adolescents aged 12-17 who self-harm: Study protocol

Isobel Greenhalgh, Jessica Tingley, Gordon Taylor, Antonieta Medina-Lara, Shelley Rhodes, P. Stallard

Research output: Contribution to journalArticlepeer-review

2 Citations (SciVal)

Abstract

Introduction A mobile app, BlueIce, was codesigned with young people with a history of self-harm to provide them with more accessible and available evidence-based support at times of distress. A preliminary evaluation found that BlueIce was acceptable, safe and used by young people and helped to reduce self-harm. The present study is designed to assess the effectiveness and cost-effectiveness of adding BlueIce to usual Child and Adolescent Mental Health Service (CAMHS). Methods and analysis This study is a single-blind, randomised controlled trial comparing usual CAMHS care with usual care plus BlueIce. A total of 138 adolescents aged 12-17 with current or a history of self-harm will be recruited through the Oxford Health National Health Service (NHS) Foundation Trust via their CAMHS clinician. The primary outcome is self-harm at 12 weeks assessed using the Risk Taking and Self-Harm Inventory for Adolescents. Secondary outcomes include mood, anxiety, hopelessness, general behaviour, sleep and impact on everyday life at 12 weeks and 6 months. Health-related quality of life and healthcare resource utilisation data will be collected at baseline, 12 weeks and 6 months. Postuse interviews at 12 weeks will determine the acceptability, safety and usability of BlueIce. Ethics and dissemination The study was approved by the NHS South Central - Oxford B NHS Research Ethics Committee (19/SC/0212) and by the Health Research Authority (HRA) and Health and Care Research Wales. Findings will be disseminated in peer review open-access journals and at academic conferences. Trial registration number ISRCTN10541045.

Original languageEnglish
Article numbere049859
JournalBMJ Open
Volume11
Issue number11
DOIs
Publication statusPublished - 23 Nov 2021

Keywords

  • child & adolescent psychiatry
  • mental health
  • suicide & self-harm
  • telemedicine

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Beating Adolescent Self-Harm (BASH): A randomised controlled trial comparing usual care versus usual care plus a smartphone self-harm prevention app (BlueIce) in young adolescents aged 12-17 who self-harm: Study protocol'. Together they form a unique fingerprint.

Cite this